Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study
Okusaka, T. Kitano, M. Chen, M. H. Chen, J. S. Ostwal, V. S. McNamara, Mairead G Breder, V. Petrova, M. Buchschacher, G. Rokutanda, N.
Okusaka, T.
Kitano, M.
Chen, M. H.
Chen, J. S.
Ostwal, V. S.
McNamara, Mairead G
Breder, V.
Petrova, M.
Buchschacher, G.
Rokutanda, N.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Okusaka T, Kitano M, Chen MH, Chen JS, Ostwal VS, McNamara MG, et al. Outcomes by disease status in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase III TOPAZ-1 study. Annals of Oncology. 2022 Nov;38(9):S1471-S. PubMed PMID: WOS:000897943700095.